Literature DB >> 19336731

Energy homeostasis and cancer prevention: the AMP-activated protein kinase.

Judith R Fay1, Vernon Steele, James A Crowell.   

Abstract

Caloric restriction has long been recognized as an extremely effective cancer preventive. Current population demographics suggest that caloric excess and obesity will lead to increased cancer incidence, underscoring the need to elucidate the molecular mechanisms that couple dysregulated energy homeostasis to aberrant cell growth. The AMP-activated protein kinase (AMPK) is a critical monitor of cellular energy status, largely studied for its importance in metabolic regulation. AMPK also controls processes relevant to tumor development, including cell cycle progression, protein synthesis, cell growth, and survival. Several tumor suppressors impinge on AMPK signaling, and activation of the kinase inhibits tumor growth. However, AMPK can also promote cancer in some settings, necessitating a more complete understanding of the complexities of this signaling network. Because dysregulated energy balance is a nexus for multiple chronic diseases of aging, drugs that target these pathways may find broad utility in aging populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336731     DOI: 10.1158/1940-6207.CAPR-08-0166

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  37 in total

Review 1.  Cancer cell signaling pathways targeted by spice-derived nutraceuticals.

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Bharat B Aggarwal
Journal:  Nutr Cancer       Date:  2011-12-09       Impact factor: 2.900

2.  AMPKα2 Regulates Bladder Cancer Growth through SKP2-Mediated Degradation of p27.

Authors:  Stavros Kopsiaftis; Katie L Sullivan; Isha Garg; John A Taylor; Kevin P Claffey
Journal:  Mol Cancer Res       Date:  2016-09-16       Impact factor: 5.852

3.  Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells.

Authors:  Junyu Ning; Gang Xi; David R Clemmons
Journal:  Endocrinology       Date:  2011-06-14       Impact factor: 4.736

4.  A fluorescent reporter of AMPK activity and cellular energy stress.

Authors:  Peiling Tsou; Bin Zheng; Chia-Hsien Hsu; Atsuo T Sasaki; Lewis C Cantley
Journal:  Cell Metab       Date:  2011-04-06       Impact factor: 27.287

5.  A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer.

Authors:  Silvia Valtorta; Gabriella Nicolini; Farida Tripodi; Cristina Meregalli; Guido Cavaletti; Federica Avezza; Luca Crippa; Gloria Bertoli; Francesca Sanvito; Paola Fusi; Roberto Pagliarin; Fulvia Orsini; Rosa Maria Moresco; Paola Coccetti
Journal:  Invest New Drugs       Date:  2014-08-19       Impact factor: 3.850

Review 6.  AMPK as a potential anticancer target - friend or foe?

Authors:  Hsiao-Ching Chuang; Chih-Chien Chou; Samuel K Kulp; Ching-Shih Chen
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 7.  Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease.

Authors:  S M Cabarcas; E M Hurt; W L Farrar
Journal:  Curr Mol Med       Date:  2010-11       Impact factor: 2.222

Review 8.  Regulation of cancer metabolism by O-GlcNAcylation.

Authors:  Zhonghua Li; Wen Yi
Journal:  Glycoconj J       Date:  2013-12-10       Impact factor: 2.916

9.  Role of fat body lipogenesis in protection against the effects of caloric overload in Drosophila.

Authors:  Laura Palanker Musselman; Jill L Fink; Prasanna Venkatesh Ramachandran; Bruce W Patterson; Adewole L Okunade; Ezekiel Maier; Michael R Brent; John Turk; Thomas J Baranski
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

10.  Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer.

Authors:  Chel Hun Choi; Joon-Yong Chung; Hanbyoul Cho; Haruhisa Kitano; Eileen Chang; Kris Ylaya; Eun Joo Chung; Jae-Hoon Kim; Stephen M Hewitt
Journal:  Pathobiology       Date:  2015-08-25       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.